ASP5541

· Astellas Pharma Global Development, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ASP5541, covering 2026-02-18 to 2026-04-02. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer [Phase 2]